Jaroslav Kuneš - Search Results

Year	Number of Results
2002	5
2003	8
2004	2
2005	2
2006	4
2007	6
2008	4
2009	3
2010	4
2011	4
2012	3
2013	2
2014	2
2015	4
2016	6
2017	5
2018	7
2019	6
2020	4
2021	6
2022	3
2023	7
2024	2

1

Prolactin-Releasing Peptide: Physiological and Pharmacological Properties.

Pražienková V, Popelová A, Kuneš J, Maletínská L. Pražienková V, et al. Among authors: kunes j. Int J Mol Sci. 2019 Oct 24;20(21):5297. doi: 10.3390/ijms20215297. Int J Mol Sci. 2019. PMID: 31653061 Free PMC article. Review.

2

Lipidization as a tool toward peptide therapeutics.

Myšková A, Sýkora D, Kuneš J, Maletínská L. Myšková A, et al. Among authors: kunes j. Drug Deliv. 2023 Dec;30(1):2284685. doi: 10.1080/10717544.2023.2284685. Epub 2023 Nov 27. Drug Deliv. 2023. PMID: 38010881 Free PMC article. Review.

3

Pathogenetic Mechanisms of Neurogenic Pulmonary Edema.

Šedý J, Kuneš J, Zicha J. Šedý J, et al. Among authors: kunes j. J Neurotrauma. 2015 Aug 1;32(15):1135-45. doi: 10.1089/neu.2014.3609. Epub 2015 Apr 24. J Neurotrauma. 2015. PMID: 25496372 Review.

4

Obesity-related hypertension: possible pathophysiological mechanisms.

Vaněčková I, Maletínská L, Behuliak M, Nagelová V, Zicha J, Kuneš J. Vaněčková I, et al. Among authors: kunes j. J Endocrinol. 2014 Dec;223(3):R63-78. doi: 10.1530/JOE-14-0368. J Endocrinol. 2014. PMID: 25385879 Review.

5

GPR160 is not a receptor of anorexigenic cocaine- and amphetamine-regulated transcript peptide.

Freitas-Lima LC, Pačesová A, Staňurová J, Šácha P, Marek A, Hubálek M, Kuneš J, Železná B, Maletínská L. Freitas-Lima LC, et al. Among authors: kunes j. Eur J Pharmacol. 2023 Jun 15;949:175713. doi: 10.1016/j.ejphar.2023.175713. Epub 2023 Apr 11. Eur J Pharmacol. 2023. PMID: 37054941 Free article.

6

Lipopeptides as therapeutics: applications and in vivo quantitative analysis.

Zemenová J, Sýkora D, Maletínská L, Kuneš J. Zemenová J, et al. Among authors: kunes j. Bioanalysis. 2017 Jan;9(2):215-230. doi: 10.4155/bio-2016-0206. Bioanalysis. 2017. PMID: 27960546 Review.

7

Prolactin-releasing peptide: a new tool for obesity treatment.

Kuneš J, Pražienková V, Popelová A, Mikulášková B, Zemenová J, Maletínská L. Kuneš J, et al. J Endocrinol. 2016 Aug;230(2):R51-8. doi: 10.1530/JOE-16-0046. J Endocrinol. 2016. PMID: 27418033 Review.

8

The impact of anorexigenic peptides in experimental models of Alzheimer's disease pathology.

Maletínská L, Popelová A, Železná B, Bencze M, Kuneš J. Maletínská L, et al. Among authors: kunes j. J Endocrinol. 2019 Feb 1;240(2):R47-R72. doi: 10.1530/JOE-18-0532. J Endocrinol. 2019. PMID: 30475219 Review.

9

Inflammation: major denominator of obesity, Type 2 diabetes and Alzheimer's disease-like pathology?

Kacířová M, Zmeškalová A, Kořínková L, Železná B, Kuneš J, Maletínská L. Kacířová M, et al. Among authors: kunes j. Clin Sci (Lond). 2020 Mar 13;134(5):547-570. doi: 10.1042/CS20191313. Clin Sci (Lond). 2020. PMID: 32167154 Review.

10

Age-related metabolic and neurodegenerative changes in SAMP8 mice.

Pačesová A, Holubová M, Hrubá L, Strnadová V, Neprašová B, Pelantová H, Kuzma M, Železná B, Kuneš J, Maletínská L. Pačesová A, et al. Among authors: kunes j. Aging (Albany NY). 2022 Sep 16;14(18):7300-7327. doi: 10.18632/aging.204284. Epub 2022 Sep 16. Aging (Albany NY). 2022. PMID: 36126192 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

89 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

89 results

Results by year